Brief: Ascelia Pharma Q4 Oper Loss Widens To SEK 52.2 Mln

Ascelia Pharma AB

10/02/2023 07:53

Feb 10 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * Q4 OPERATING RESULT OF SEK -52.2M (SEK -39.2M)
    * OUR PROGRESS IN DEVELOPMENT OF ORVIGLANCE IN Q4 SETS US ON
COURSE FOR A SUCCESSFUL 2023

Source text for Eikon:  ID:nMFN9whSJN 
Further company coverage:  ACELP.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))